WORLDWIDE PHARMACOVIGILANCE ( WHO) : Accutane, Propecia, isotretinoin, finasteride, roaccutane, proscar, isotretinoïne

[stephane1]

Hello,

it’s extremely important to report your adverse effects to the PHARMACOVIGILANCE of your country, as the current data is 100 times lower than reality ( see charts made with WHO figures availables on http://www.vigiaccess.org/).

Thank you fill out your form reporting adverse health events and disorders :

USA : https://www.fda.gov/…/fda-re…/individual-case-safety-reports

UK : https://www.gov.uk/report-problem-medicine-medical-device

Europe : https://www.ema.europa.eu/…/over…/pharmacovigilance-overview

it will take a few tens of minutes but it can change future lives, thank you.

Accutane, isotretinoin, roaccutane, isotretinoïne, :
Currently, the total and global number of records retrieved by the WHO on roaccutane is:

62 890 cases (to be multiplied by 100 to get the actual figure …).

Thanks you!

[Greek]

It’s worth noting that this condition is the same, whatever the substance that brought you here.

So even if the drug you took isn’t mentioned in the title - report your adverse reaction.

[stephane1]

@Greek, I planned for tomorrow to do the same graphics for finasteride, in another parallel subject, for the sake of clarity and organization…

[Greek]

Not a criticism, maybe do it all in the same topic? We’re all about unity. It’s good for PFS guys to see Accutane people dealing with the same thing, also for Accutane people to see PFS guys have the same issues.

Getting together is better than separating.

[stephane1]

Ok, as you wish. This question about organisation is important, i feel.

[stephane1]

Propecia, proscar, finasteride
Currently, the total and global number of case reports collected by WHO on finasteride is:
15,776 cases of pharmacovigilance.
(multiply by 100 to get the actual figure).

[Dubya_B]

@stephane1, nice work!

Were you able to create those charts within Vigiaccess, or did you use data from Vigiaccess to make them yourself?

For example, if I would like to find out the worldwide number of 12-17 year-olds reporting lower back pain from Sertraline vs the number of 12-17 year-olds reporting lower back pain from all other drugs, is there a way for me to do this within Vigiaccess?

[stephane1]

Hello, @Dubya_B,
thank you, it’s always nice to have encouragement
No, alas, there is no GUI on vigiaccess, you have to do everything by hand …
if you want to know some comparisons, you have to go directly on vigiacces the raw data, it is without registration

[Dubya_B]

Thanks. Hopefully these public interfaces available through the FDA, MHRA, EMA, and WHO, are not the same as what those who work at these pharmacovigilance agencies must use. They’re terrible, but better than nothing.

[stephane1]

Alas, I believe that if …
for example, you have the canadian data cube with graphic interface in those posts above, which is quite well done (but the data is limited) :

data-mining interactive and ergonomic canada that works:

Infobase de la santé publique - Canada.ca

Infobase de la santé publique - Canada.ca

visible at

https://forum.propeciahelp.com/t/en-reflexion-centralisation-des-datas-et-bases-de-donnees-psychiatriques-par-pays-en-vue-danalyses-statistiques-plurifactorielles/37419/3

and

https://forum.propeciahelp.com/t/in-reflection-centralization-of-datas-and-psychiatric-databases-by-country-for-multi-factorial-statistical-analyzes/37416/6

There is something to do with all data by country, a work to llink and cross all of that

I admit that my main project is to do an amateur epidemic study, self-taught, but it’s complicated with my symptoms … and alone.

cheers

[Dubya_B]

Well, I do hope if you find a signal while doing an amateur epidemiological study, that you go to the professionals with your information as well as sharing with us.

I’ve noticed that often these agencies like the FDA will make their database available, so you don’t have to necessarily rely on their crappy public interface.

[stephane1]

Thanks, Without being part of a lab, without money, I have access to basic data, but there is already something to do, if only to highlight correlations, and independent research tracks . In any case, it is the data that is interresting, their mediocre interfaces do not matter much.